...
首页> 外文期刊>Pathology case reviews. >Pulmonary Cytopathology Current Concepts in Lung Cancer
【24h】

Pulmonary Cytopathology Current Concepts in Lung Cancer

机译:肺癌的肺细胞病理学现状

获取原文
获取原文并翻译 | 示例
           

摘要

The molecular era is upon us! The complexity of testing and management of information has led to targeted therapeutics and personalized medicine. There is greater emphasis on sophisticated diagnostic modalities and multidisciplinary approach to patient management. Cytopathology must adapt and is adapting to meet the needs of this rapidly changing environment and the increasingly dynamic relationships with our clinical and radiology colleagues. The basic cytologic criteria for primary pulmonary carcinomas have remained relatively static over the last decade. Now there is increasing pressure to locate and diagnose pulmonary lesions early and to collect material for Bronchoscopically and radiologically guided fine needle aspirations have been the mainstays of procurement for pulmonary specimens; however, their ability to visualize and sample lesions in the lung has advanced dramatically and has highlighted the need for greater interaction with radiologists and pulmonologists. This was the subject of the State of the Art Symposium at the 56th Annual Meeting of the American Society of Cytopathology in November 2008 in Orlando, Florida. This issue of Pathology Case Reviews continues this dialogue and highlights current concepts in the detection, diagnosis, and management of lung cancer.
机译:分子时代已经来临!信息测试和管理的复杂性导致了针对性的疗法和个性化医学。更加注重复杂的诊断方式和患者管理的多学科方法。细胞病理学必须适应并且正在适应这种快速变化的环境以及与我们的临床和放射学同事之间日益动态的关系的需求。在过去十年中,原发性肺癌的基本细胞学标准一直保持相对稳定。现在,越来越需要尽早定位和诊断肺部病变以及为支气管镜和放射学指导的细针穿刺收集材料的压力越来越大,这已成为采购肺标本的主要手段。但是,它们可视化和采样肺部病变的能力已大大提高,并突出显示了需要与放射科医生和肺科医生进行更大程度的互动。这是2008年11月在佛罗里达州奥兰多举行的美国细胞病理学学会第56届年会上最新技术专题讨论会的主题。本期《病理学案例评论》继续了这一对话,并重点介绍了肺癌检测,诊断和管理中的最新概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号